Renal Dialysis Clinical Trial
— BalanceWise-HDOfficial title:
Intervention to Reduce Dietary Sodium in Hemodialysis
| Verified date | August 2017 |
| Source | University of Pittsburgh |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to test, in a randomized clinical trial of 200 hemodialysis patients, a behavioral intervention to reduce dietary sodium intake. The investigators will assess the impact on weight gain between dialysis treatments, blood pressures, symptoms, and health-related quality of life. The primary study hypotheses are that participants will gain less weight in between dialysis treatments, and that dietary recalls will demonstrate reduced consumption of dietary sodium.
| Status | Completed |
| Enrollment | 179 |
| Est. completion date | September 2012 |
| Est. primary completion date | September 2012 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Individuals with end stage renal disease (ESRD) who are 18 years of age or older, - Individuals who are literate, - Community-dwelling adults who have been receiving maintenance dialysis for at least 3 months. Exclusion Criteria: - Individuals who cannot read or write, - Individuals who do not speak English, - Individuals who plan to move out of the area or change dialysis centers within the next 6 months, - Individuals who have a life expectancy of less than 12 months, - Individuals who are scheduled for a living donor transplant, - Individuals who cannot see the PDA screen or use the stylus to make food selections from the PDA screen, or - Individuals who live in an institutional setting in which they would have limited control over their dietary intake. |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Pittsburgh School of Medicine | Pittsburgh | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| University of Pittsburgh | National Institute of Nursing Research (NINR), University of Iowa |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Time Specific Interdialytic Weight Gain (Baseline) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to baseline measurement. | Baseline | |
| Primary | Time Specific Interdialytic Weight Gain (8 Weeks) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to the 8-week measurement time point. | 8 weeks | |
| Primary | Time Specific Interdialytic Weight Gain (12 Weeks) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to the 12 week measurement time point. | 12 weeks | |
| Primary | Time Specific Interdialytic Weight Gain (16 Weeks) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to the 16 week measurement time point. | 16 weeks | |
| Primary | Time Specific Dietary Sodium Intake (Baseline) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | Baseline | |
| Primary | Time Specific Dietary Sodium Intake (8 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | 8 weeks | |
| Primary | Time Specific Dietary Sodium Intake (16 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | 16 weeks | |
| Primary | Time Specific Change From Baseline in Dietary Sodium Intake (Baseline to 8 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. The difference between measurement time points was determined. | Baseline to 8 weeks | |
| Primary | Time Specific Change From Baseline in Dietary Sodium Intake (Baseline to 16 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | Baseline to 16 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05189795 -
The Construction of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
|
||
| Completed |
NCT00730145 -
A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis
|
Phase 1 | |
| Completed |
NCT00806130 -
Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients
|
||
| Completed |
NCT00753116 -
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
|
Phase 1 | |
| Completed |
NCT05718765 -
The Effect of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
|
N/A | |
| Completed |
NCT03250715 -
Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure
|
N/A | |
| Completed |
NCT05469620 -
Adaptive Nutrition Therapy in Hemodialysis
|
N/A | |
| Completed |
NCT03536858 -
Social Networks and Renal Education: Promoting Transplantation
|
N/A | |
| Completed |
NCT00824837 -
Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane
|
Phase 1/Phase 2 | |
| Completed |
NCT03403491 -
Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis
|
N/A | |
| Terminated |
NCT02495662 -
The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation
|
Phase 2 | |
| Completed |
NCT01179620 -
Certoparin in Renal Patients Undergoing Hemodialysis
|
Phase 3 | |
| Completed |
NCT01017276 -
A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
|
Phase 3 | |
| Active, not recruiting |
NCT04466865 -
A Communication Tool to Assist Older Adults Facing Dialysis Choices
|
N/A | |
| Recruiting |
NCT03782519 -
Quality of Life of Frail Aged Patients in Incremental Hemodialysis
|
N/A | |
| Recruiting |
NCT02843334 -
Study of the Prevalence of Fabry Disease in French Dialysis Patients
|
N/A | |
| Recruiting |
NCT02545530 -
Transdermal Clonidine in Chronic Hemodialysis Patients
|
N/A | |
| Completed |
NCT00892749 -
Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
|
Phase 3 | |
| Completed |
NCT00649298 -
A Clinical Trial of IntensiVE Dialysis
|
Phase 4 | |
| Completed |
NCT05833451 -
Reiki in Symptom Management of Hemodialysis Patients
|
N/A |